Skip to main content

Cardiovascular Drugs and Therapy

Ausgabe 3/2017

Inhalt (12 Artikel)

ORIGINAL ARTICLE

Empagliflozin Improves Left Ventricular Diastolic Dysfunction in a Genetic Model of Type 2 Diabetes

Nadjib Hammoudi, Dongtak Jeong, Rajvir Singh, Ahmed Farhat, Michel Komajda, Eric Mayoux, Roger Hajjar, Djamel Lebeche

SHORT COMMUNICATION

The Role of MKP-1 in Insulin-Induced Cardioprotection

Ingrid Webster, Angelique Smith, Amanda Lochner, Barbara Huisamen

ORIGINAL ARTICLE

Plasma Lipidome Analysis by Liquid Chromatography-High Resolution Mass Spectrometry and Ion Mobility of Hypertriglyceridemic Patients on Extended-Release Nicotinic Acid: a Pilot Study

Véronique Ferchaud-Roucher, Mikaël Croyal, Thomas Moyon, Yassine Zair, Michel Krempf, Khadija Ouguerram

Open Access ORIGINAL ARTICLE

Identifying Subpopulations with Distinct Response to Treatment Using Plasma Biomarkers in Acute Heart Failure: Results from the PROTECT Trial

Licette C. Y. Liu, Mattia A. E. Valente, Douwe Postmus, Christopher M. O’Connor, Marco Metra, Howard C. Dittrich, Piotr Ponikowski, John R. Teerlink, Gad Cotter, Beth Davison, John G. F. Cleland, Michael M. Givertz, Daniel M. Bloomfield, Dirk J. van Veldhuisen, Hans L. Hillege, Peter van der Meer, Adriaan A. Voors

ORIGINAL ARTICLE

Effect of Apixaban on All-Cause Death in Patients with Atrial Fibrillation: a Meta-Analysis Based on Imputed Placebo Effect

Patrícia O. Guimarães, Renato D. Lopes, Daniel M. Wojdyla, Azmil H. Abdul-Rahim, Stuart J. Connolly, Greg C. Flaker, Junyuan Wang, Michael Hanna, Christopher B. Granger, Lars Wallentin, Kennedy R. Lees, John H. Alexander, John J.V. McMurray

ORIGINAL ARTICLE

Primary Care Physician Perspectives on Barriers to Statin Treatment

Rikki M. Tanner, Monika M. Safford, Keri L. Monda, Benjamin Taylor, Ronan O’Beirne, Melanie Morris, Lisandro D. Colantonio, Ricardo Dent, Paul Muntner, Robert S. Rosenson

REVIEW ARTICLE

The Role of SGLT-2 Inhibitors as Part of Optimal Medical Therapy in Improving Cardiovascular Outcomes in Patients with Diabetes and Coronary Artery Disease

Wassim Mosleh, Abhinav Sharma, Mandeep S. Sidhu, Brian Page, Umesh C. Sharma, Michael E. Farkouh

REVIEW ARTICLE

Triple Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing PCI: a Fading Role

Dimitrios Alexopoulos, Panagiotis Vlachakis, John Lekakis

Open Access REVIEW ARTICLE

MicroRNAs in Atrial Fibrillation: from Expression Signatures to Functional Implications

Nicoline W. E. van den Berg, Makiri Kawasaki, Wouter R. Berger, Jolien Neefs, Eva Meulendijks, Anke J. Tijsen, Joris R. de Groot

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.